In conclusion, our results suggest that activating astroglial α7 nAChRs may have a role in neuroprotection by decreasing inflammation and oxidative stress, and therefore could have therapeutic implications for the development of disease modifying treatments for neurodegenerative diseases. This evidence concerns the gene CHRNA7 and neurodegenerative disease.